Clinical Trial

Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1

Study acronym: DINGO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Trial Details
NCT Number NCT07552922
Lead Sponsor St Vincent's Hospital, Sydney
Collaborators: University of Technology, Sydney
Conditions Prostate Cancer (Adenocarcinoma)
Enrollment 24 participants
Start Date 2025-12-01
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-27